Crossmark

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus

Published Online: 2020-04-08

Published Print: 2020-05

Authors

Jakhar, Deepak http://orcid.org/0000-0002-5516-8295
Kaur, Ishmeet
License Information

Text and Data Mining valid from 2020-04-08

Version of Record valid from 2020-04-08
More Information

Article History

First Online: 8 April 2020

Competing interests

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current